Comments
Loading...
Chromocell Therapeutics (CHRO) Forecast
NewsEarningsChromocell Therapeutics (CHRO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestChromocell Therapeutics (AMEX:CHRO) Stock Quotes, Forecast and News Summary
Chromocell Therapeutics Stock (AMEX: CHRO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Chromocell Therapeutics (CHRO) stock?
You can purchase shares of Chromocell Therapeutics (AMEX:CHRO) through any online brokerage.
Who are Chromocell Therapeutics (CHRO) competitors?
Other companies in Chromocell Therapeutics’s space includes: Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI), Portage Biotech (NASDAQ:PRTG) and AquaBounty Techs (NASDAQ:AQB).
What is the forecast, or price target, for Chromocell Therapeutics (CHRO) stock?
There is no analysis for Chromocell Therapeutics to provide a consensus price target.
What is the current price for Chromocell Therapeutics (CHRO)?
The stock price for Chromocell Therapeutics (AMEX: CHRO) is $0.65 last updated November 21, 2024 at 8:11 AM EST.
Does Chromocell Therapeutics (CHRO) pay a dividend?
There are no upcoming dividends for Chromocell Therapeutics.
When is Chromocell Therapeutics (AMEX:CHRO) reporting earnings?
Chromocell Therapeutics’s Q4 earnings are confirmed for Thursday, February 20, 2025.
Is Chromocell Therapeutics (CHRO) going to split?
There is no upcoming split for Chromocell Therapeutics.
What sector and industry does Chromocell Therapeutics (CHRO) operate in?
Chromocell Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.